Skip to main content

An overview on Benzothiazinone analogs as Antitubercular Drugs

 

Clinical courses

Magazine Home


MAY 2015 ARTICLE LIST >>

PharmaTutor (May- 2015)

 

Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 3, Issue 5)

 

Received On: 10/01/2015; Accepted On: 02/03/2015; Published On: 01/05/2015

 

AUTHORS: Mohammad Asif
Department of Pharmacy, GRD (PG) Institute of Management & Technology,
Dehradun, Uttarakhand, India
aasif321@gmail.com

 

ABSTRACT: The reappearance of tuberculosis and the rush of multidrug-resistant clinical isolates of Mycobacterium tuberculosis have reaffirmed tuberculosis as a key public health concern. Describe findings on the pharmacological status of Benzothiazinones as new agents that are being developed as antitubercular drugs. Benzothiazinones act by targeting the enzymes responsible for the formation of arabinans that are essential parts of the cell wall. In view of their novel mechanism of action, these drugs appear promising as anti-TB drugs and considered to be promising candidates for future development.

 

How to cite this article: M Asif; An overview on Benzothiazinone analogs as Antitubercular Drugs; PharmaTutor; 2015; 3(5); 15-18

 

[ABSTRACT WITH CITATION]   [VIEW AS HTML]